• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Immune system discovery could aid quest for stem cell therapies

Bioengineer by Bioengineer
May 14, 2019
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A discovery of how stem cells are protected from viruses could inform the development of therapies for use in medicine, research suggests.

The finding could help research aimed at boosting the immune response of stem cells – early stage cells with the potential to become specialised tissues – for use in treating disease or damaged tissues.

The research identified ways to switch on a key part of the immune system that protects against viruses in stem cells, known as the interferon response.

Researchers from the University of Edinburgh studied stem cells from mouse embryos to understand how stem cells can develop resistance to viruses, before they become specialised cells.

The team discovered a protein – known as mitochondrial antiviral signalling protein (MAVS) – that switches on this immune response in stem cells.

A small molecule – known as miR-673 – was found to regulate when the MAVS protein is turned on and off.

When miR-673 was removed from in stem cells in the lab, production of the MAVS protein was restored, switching on the anti-viral response.

The same mechanism is likely to operate in humans, researchers say. This antiviral response may be absent from embryonic stem cells as it can disrupt development.

Researchers hope that their findings will make the use of stem cells more efficient, to one day be given to patients to replace cells lost or damaged by degenerative diseases such as Parkinson’s or diabetes. The study, published in eLife, was funded by Wellcome.

Jeroen Witteveldt, of the University of Edinburgh’s School of Biological Sciences, who took part in the study, said: “Unveiling how this crucial antiviral mechanism is switched off, and methods to switch this back on in a controlled manner, could make stem cell therapies much more efficient.”

###

Media Contact
Catriona Kelly
[email protected]

Related Journal Article

https://www.ed.ac.uk/news/2019/immune-find-could-aid-stem-cell-therapy-quest
http://dx.doi.org/10.7554/eLife.44171

Tags: BiologyCell BiologyDevelopmental/Reproductive BiologyInfectious/Emerging DiseasesVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

Jaw by jaw: How biting shaped the evolution of fish

September 2, 2025

New Research Reveals Role of Exosomes in Biological Aging

September 2, 2025

Boosting Meiotic Crossovers via Heterozygous-Homozygous Juxtaposition

September 2, 2025

Streamlined Success: How Gene Loss Fuels the Adaptive Evolution of a Pandemic Bacterium

September 2, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    154 shares
    Share 62 Tweet 39
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    143 shares
    Share 57 Tweet 36
  • Needlestick Injury Rates in Nurses and Students in Pakistan

    122 shares
    Share 49 Tweet 31
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    117 shares
    Share 47 Tweet 29

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unlocking CGM Benefits for Diabetic Seniors

Identifying Progression Risks to Albuminuria in Diabetes

Exploring Tennis Racket Feel: Impact Parameters and Properties

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.